Investors finally get a glimpse of Agilon Health Inc (AGL) volume hitting the figure of 3.48 million.

On Monday, Agilon Health Inc (NYSE: AGL) was 3.23% up from the session before settling in for the closing price of $2.17. A 52-week range for AGL has been $1.50 – $13.76.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company grew by 53.71% over the past five years. When this article was written, the company’s average yearly earnings per share was at -19.13%. With a float of $303.27 million, this company’s outstanding shares have now reached $411.96 million.

Let’s look at the performance matrix of the company that is accounted for 1117 employees. In terms of profitability, gross margin is -1.22%, operating margin of -6.17%, and the pretax margin is -5.56%.

Agilon Health Inc (AGL) Insider and Institutional Ownership

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Agilon Health Inc stocks. The insider ownership of Agilon Health Inc is 26.39%, while institutional ownership is 80.57%. The most recent insider transaction that took place on Sep 12 ’24, was worth 67,188. In this transaction CEO & President of this company bought 20,000 shares at a rate of $3.36, taking the stock ownership to the 67,590 shares.

Agilon Health Inc (AGL) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around -19.13% per share during the next fiscal year.

Agilon Health Inc (NYSE: AGL) Trading Performance Indicators

You can see what Agilon Health Inc (AGL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.16.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.36 in one year’s time.

Technical Analysis of Agilon Health Inc (AGL)

Agilon Health Inc (NYSE: AGL) saw its 5-day average volume 2.88 million, a negative change from its year-to-date volume of 4.88 million. As of the previous 9 days, the stock’s Stochastic %D was 63.73%. Additionally, its Average True Range was 0.22.

During the past 100 days, Agilon Health Inc’s (AGL) raw stochastic average was set at 12.09%, which indicates a significant decrease from 82.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 104.58% in the past 14 days, which was lower than the 111.95% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.58, while its 200-day Moving Average is $4.76. Nevertheless, the first resistance level for the watch stands at $2.29 in the near term. At $2.35, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.44. If the price goes on to break the first support level at $2.14, it is likely to go to the next support level at $2.05. The third support level lies at $1.99 if the price breaches the second support level.

Agilon Health Inc (NYSE: AGL) Key Stats

There are 412,018K outstanding shares of the company, which has a market capitalization of 906.22 million. As of now, sales total 4,316 M while income totals -262,600 K. Its latest quarter income was 1,451 M while its last quarter net income were -117,620 K.